Pfizer Shots Look Effective To Kids: FDA

U.S. health regulators say that child-sized doses of Pfizer’s COVID-19 vaccine are very effective in preventing sexually transmitted infections in elementary school children, as the United States is considering starting vaccination of young people. , States that it does not cause unexpected safety problems.

The Food and Drug Administration posted an analysis of Pfizer’s data on Friday to discuss whether shots are ready for about 28 million children between the ages of 5 and 11 before next week’s public meeting. Did.

The agency asks a panel of external vaccine experts to vote for the question.

In their analysis, FDA scientists conclude that in almost all scenarios, the benefits of vaccines to prevent hospitalization and death from COVID-19 outweigh the serious potential side effects of children.

However, agency reviewers have stopped requiring Pfizer’s shots to be approved.

The agency will ask the question to a panel of independent advisors on Tuesday and weigh their advice before making their own decisions.

If the FDA approves the shot, the Centers for Disease Control and Prevention will make additional recommendations as to who should receive the shot in the first week of November.

Children could start vaccination early next month and the first young people were fully protected by Christmas.

Full-strength Pfizer shots are already recommended for people over the age of 12, but pediatricians and many parents have sent young children to school to stop infections from highly contagious delta variants. I am anxious for protection to help you get rid of it.

An FDA review confirmed Pfizer’s results posted earlier in the day, showing that double-dose shots were nearly 91% effective in preventing symptomatic infections in infants.

Pfizer Shots Look Effective To Kids: FDA

Source link Pfizer Shots Look Effective To Kids: FDA

Related Articles

Back to top button